Conclusion
The COVID-19 pandemic continues to present innumerable unique challenges throughout the healthcare system. Otolaryngology is an especially challenging subspecialty at this time, with the intrinsic exposure risks to providers of procedures that generate aerosols. Practice is even more complicated when patients present with complex cancers and coincident immunosuppression. Clinical decision-making requires careful weighing of the competing risks of various approaches, and honest communication with the patient. A comprehensive, multidisciplinary approach, including the addition of specialties such as Infectious Disease, is the preferred approach to managing these patients in these unusual circumstances.